INDP
Indaptus Therapeutics Inc

15,842
Loading...
Loading...
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7

Frequently Asked Questions

What is Market Cap of Indaptus Therapeutics Inc?
What is the 52-week high for Indaptus Therapeutics Inc?
What is the 52-week low for Indaptus Therapeutics Inc?
What is Indaptus Therapeutics Inc stock price today?
What was Indaptus Therapeutics Inc stock price yesterday?
What is the PE ratio of Indaptus Therapeutics Inc?
What is the Price-to-Book ratio of Indaptus Therapeutics Inc?
What is the 50-day moving average of Indaptus Therapeutics Inc?
How many employess does Indaptus Therapeutics Inc has?

Latest INDP News

View

Advertisement. Remove ads.

Advertisement. Remove ads.